Diligence memo · auto-generated · as of July 2, 2026

Apnex Medical, Inc

Apnex Medical, Inc looks fair against its niche peers and is dormant on financing cadence.

DeprioritizeFinancing has gone silent well past the sector's normal cadence — treat as inactive until outside confirmation of a live operation.

Businessfiled

Apnex Medical, Inc operates in Other Health Care, based in ST. PAUL.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Apnex Medical, Inc has raised $34M in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Series B (a $15M–$40M round).

Largest single filing: $20M on 2011-09-26.

Most recent recorded round closed around 2011-09-26.

Valuation (modeled)modeled

Provath models Apnex Medical, Inc at approximately $443M (range $47M–$1.7B). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Fair. Modeled value is 1.03× the median modeled value of Series B Other Health Care companies in 2010–2012 (50 peers) — value vs value, same stage and era. Within the normal band (103% of peer median) for its niche.

Financing rhythm & timingmixed

Historic cadence: a new round about every 22 months.

Last raise 14.8 yr ago; this sector typically re-raises about every 14 months.

Silent for over 3× the sector's normal cadence.

The last round stepped up 1.4× from the prior — scaling.

Comparablesmixed

Capital scale ranks ahead of 89% of Other Health Care peers (5377 compared).

Modeled value ranks above 93% of those peers.

Closest niche peers: Cell MDX, LLC, OptiMedica Corp, Riverchase Holdings Mso, Llc, CDRT Holding Corp, Pivot Medical Inc.

Peoplefiled

10 named people on file across officers, directors and signatories.

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.